Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I think that's a bigger consideration than you think Frankie. After all it's why labs give out two tubes to start with. If plenty of labs start to adopt the EDTA then Streck tube manufacturers won't be very happy I guess.
agreed! cost savings will be the key, however they totally converted one lab onto Ygen's systems not knowing about the cost savings at the time. Just happy to get the better accuracy. So that says a lot knowing customers will adopt just for the accuracy alone. So the key disruptors are;
1; Better accuracy
2; smaller blood sample needed
3; much cheaper EDTA tubes (needs only one , not two Streck tubes)
Any more anyone can think of?
Did you see the CMD presentation? I think there is enough evidence there to show it's real and works according to the likes of Labcorp and a few very credible uni's.. No problems on that score !
Just joking, brilliant story that's all.
But on the other hand you can see why people don't just jump into these things.
Needs some time that's all.
not sure what your point in other than you think Ranger is all a fraud!?
Theranos, sorry.
It's more sensitive and uses smaller samples.
Google, Theranons !!! Haha
apart from the obvious cost saving on the tubes !
so how and who will it disrupt? What is the 'revolution' game changer exactly?
Not sure myself tbh. Does Ranger need to work with Illumina machines or can it work independently. If it doesn't need Illumina then that's why it's disruptive, in a mahooosive way too.
When you come out with things like 'disruptive' and 'revolution' then it had better be bloody good! Does anyone know exactly who and how this 'disrupts'? Is it Illumina, TF and will it disrupt their expensive machinery sales. Is it Streck tubes, where the EDTA tubes will win out, or maybe both?
be pointless selling now if they reckon they are on the cusp of disruptive tech . Just need to prove it now, and if it's as good as they say, then there will be more than one interested party I feel. It's good to hear independents like Labcorp, Laval uni etc confirming that Ranger is indeed very good.
I think the summer was mentioned, not long to wait then?
Yup, who knows.
I doubt it though. I think a sale is the plan but years off. IdI like it this year meaning actively in play working towards it today. Alas, it's not plan A for the BOD unfortunately. Aimho
Twix, who knows, they might be looking to prove up Ranger a bit more ,then sell?
If Ranger was the first or second great hope I'd be on-board. Not when the 5th or 6th+ over many years looking at how we were kept invested before and what happened. The BOD wanted to rescue their credibility but I just feel I'd settle for 15p+ now as so little has EVER gone as expectation indicated. I'm cynical. There's always a reason for delay or disappointment. Maybe Ranger is the ONE. I expect we will find out as no sale likely. I'd prefer 15p+ after pumped and bidding war could be more
I'm expecting a few partners to be announced with this new step change going forward.
Too much gravy left on this train to sell just now. Milk a year or two more salary first. Just keep your vision on the coming disruptive revolution Twix!
Simply SELL THE COMPANY. JOB DONE. FINALLY!!!
Always on the cusp of the latest promise. The story is great. Heck, I'm a believer!
It needs some umph and real progress visibly achieved and evidenced as such. Otherwise it's one promised expectation after the last, which was delayed, disappeared, failed or with hiccup.
I'm praying Ranger is the ONE finally thats DELIVERED in mya lifetime!!
As mentioned.....drop as predictable as falling off a log. Price goes up, news out, posters wet themselves, I expect the usual retrace, Nutjob has his usual attack, price drops....Nutjob has another go. Apart from the last bit, it's played out again as itI has for 2 + years illustrating a small drop in a big stream which until real, material, substantive detailed news with figures arrives just keeps on rollin'
employees/insiders selling out for their small overnight gain no doubt?
A good idea as they don't waste time money and effort working on different things. Work with the lab for the end product the lab/customer actually wants.
'making a step change in how we work with Nipt providers'. 'The traditional lab/manufacturer relationship is outdated, and doesn't reflect our patient centric vision'. So, more partnerships is the way forward, at least for Nipt anyway.
I think the market realises that covid revenue won't be replaced, in the short term at least. I think it needs to see good growth in the states. and they are very well positioned for that . They also need to get on quickly with cost savings, which I believe they are doing. I agree, the oncology sector could well be huge too! Labcorp seem very happy with the Ranger tech, and rightly so, more will follow no doubt.
SS will deliver!!